Prognostic Implications of Isolated Tumor Cells and Micrometastases in Sentinel Nodes of Patients with Invasive Breast Cancer: 10-Year Analysis of Patients Enrolled in the Prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study

Journal of the American College of Surgeons

Volumn 208, Issue 3, 2009, Pages 333-340

  Reed, Jennifer ^a   Rosman, Martin ^a   Verbanac, Kathryn M ^b   Mannie, Ann ^b   Cheng, Zandra ^a   Tafra, Lorraine ^a  

^a ANNE ARUNDEL MEDICAL CENTER   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER RECURRENCE; CELL ISOLATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL SCHOOL; MICROMETASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; UNITED STATES;

EID: 60149096826     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2008.10.036     Document Type: Article

References (30)

1. Cote R.J., Peterson H.F., Chaiwun B., et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354 (1999) 896-900
2. Rampaul R.S., Miremadi A., Pinder S.E., et al. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res 3 (2001) 113-116
3. Pargaonkar A.S., Beissner R.S., Snyder S., et al. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med 127 (2003) 701-705
4. Ryden L., Chebil G., Sjostrom L., et al. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy. Eur J Surg Oncol 33 (2007) 33-38
5. Bolster M.J., Bult P., Schapers R.F., et al. Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients. Ann Surg Oncol 13 (2006) 1466-1473
6. Tafra L., Lannin D.R., Swanson M.S., et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233 (2001) 51-59
7. Hudis C.A., Barlow W.E., Costantino J.P., et al. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol 25 (2007) 2127-2132
8. Calhoun K.E., Hansen N.M., Turner R.R., et al. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190 (2005) 588-591
9. Gipponi M., Canavese G., Lionetto R., et al. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases. Eur J Surg Oncol 32 (2006) 143-147
10. van Rijk M.C., Peterse J.L., Nieweg O.E., et al. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer 107 (2006) 467-471
11. Houvenaeghel G., Nos C., Mignotte H., et al., Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement-Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 24 (2006) 1814-1822
12. Cserni G., Gregori D., Merletti F., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91 (2004) 1245-1252
13. Cox C.E., Kiluk J.V., Riker A.I., et al. Significance of sentinel node micrometastases in human breast cancer. J Am Coll Surg 206 (2008) 261-268
14. Turner R.R., Weaver D.L., Cserni G., et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol 26 (2008) 258-263
15. Kamath V.J., Giuliano R., Dauway E.L., et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 136 (2001) 688-692
16. Weiser M.R., Montgomery L.L., Tan L.K., et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8 (2001) 145-149
17. Chu K.U., Turner R.R., Hansen N.M., et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?. Ann Surg 229 (1999) 536-541
18. Reynolds C., Mick R., Donohue J.H., et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?. J Clin Oncol 17 (1999) 1720-1726
19. Alran S., De Rycke Y., Fourchotte V., et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 14 (2007) 2195-2201
20. Rutgers E.J. Sentinel node biopsy: Interpretation and management of patients with immunohistochemisty-positive sentinel nodes and those with micrometastases. J Clin Oncol 26 (2008) 698-702
21. Kahn H.J., Hanna W.M., Chapman J.A., et al. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Breast J 12 (2006) 294-301
22. Fournier K., Schiller A., Perry R.R., et al. Micrometastasis in sentinel lymph nodes of breast cancer does not mandate completion axillary dissection. Ann Surg 239 (2004) 859-863
23. Susnik B., Frkovic-Grazio S., and Bracko M. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up. Ann Surg Oncol 11 (2004) 568-572
24. Group ILBCS. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet 335 (1990) 1565-1568
25. Alberti S., Querzoli P., Pedriali M., et al. Axillary lymph node nanometastases are prognostic factors for metastatic relapse in breast cancer patients. Clin Cancer Res 12 (2006) 6696-6701
26. Chen S.L., Hoehne F.M., and Giuliano A.E. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14 (2007) 3378-3384
27. de Mascarel I., Bonichon F., Coindre J.M., et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 66 (1992) 523-527
28. Rosen P.P., Saigo P.E., Braun D.W., et al. Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg 194 (1981) 585-591
29. Sedmak D.D., Meineke T.A., Knechtges D.S., et al. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 2 (1989) 516-520
30. Langer I., Guller U., Berclaz G., et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245 (2007) 452-461